文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions.

作者信息

Wolf Tobias, Calisan Kerim Kadir, Stitz Jörn, Barbe Stéphan

机构信息

Research Group Medical Biotechnology and Bioengineering, Faculty of Applied Natural Sciences, TH Köln-University of Applied Sciences, Leverkusen, Germany.

Institue of Technical Chemistry, Leibniz University Hannover, Hannover, Germany.

出版信息

Front Bioeng Biotechnol. 2024 May 27;12:1367405. doi: 10.3389/fbioe.2024.1367405. eCollection 2024.


DOI:10.3389/fbioe.2024.1367405
PMID:38860137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11163053/
Abstract

HIV Gag virus-like particles (HIV Gag VLPs) are promising HIV vaccine candidates. In the literature, they are often described as shear-sensitive particles, and authors usually recommend the operation of tangential flow filtration (TFF) gently at shear rates below 4,000 s to 6,000 s. This in turn poses a severe limitation to the performance of TFF-mediated concentration of VLPs, which would be substantially enhanced by working at higher shear rates. To our knowledge, studies examining the shear sensitivity of HIV Gag VLPs and providing detailed information and evidence for the fragility of these particles have not been conducted yet. Thus, we investigated the effect of high shear rates on the colloidal stability of mosaic VLPs (Mos-VLPs) as relevant examples for HIV Gag VLPs. For this purpose, Mos-VLPs were exposed to different shear rates ranging from 3,395 s to 22, 365 s for 2 h. The average hydrodynamic diameter (AHD) and the polydispersity index (PDI) of the associated particle size distribution were used as stability indicators and measured after the treatment and during storage through dynamic light scattering. At high shear rates, we observed an increase in both AHD and PDI during the storage of HIV VLPs (bVLP-without envelope proteins) and VLPs (eVLP-with envelope proteins). eVLPs exhibited higher colloidal stability than bVLPs, and we discuss the potential stabilizing role of envelope proteins. We finally demonstrated that the dispersion medium also has a considerable impact on the stability of Mos-VLPs.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/11163053/e72b363a1728/fbioe-12-1367405-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/11163053/9bf2a0db1174/fbioe-12-1367405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/11163053/e72b363a1728/fbioe-12-1367405-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/11163053/9bf2a0db1174/fbioe-12-1367405-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/11163053/e72b363a1728/fbioe-12-1367405-g002.jpg

相似文献

[1]
The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions.

Front Bioeng Biotechnol. 2024-5-27

[2]
Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.

Virology. 2022-3

[3]
Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells.

J Virol Methods. 2013-10-21

[4]
Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.

Vaccine. 2016-6-17

[5]
Production, purification and immunogenicity of Gag virus-like particles carrying SARS-CoV-2 components.

Vaccine. 2024-1-1

[6]
Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.

Vaccine. 2017-7-24

[7]
A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration.

Membranes (Basel). 2022-12-9

[8]
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.

Viruses. 2019-2-16

[9]
Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP.

Vaccine. 2019-7-9

[10]
Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein.

Nanotechnology. 2022-9-12

引用本文的文献

[1]
Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses.

Vaccines (Basel). 2025-4-23

本文引用的文献

[1]
Downstream process design for Gag HIV-1 based virus-like particles.

Biotechnol Bioeng. 2023-9

[2]
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses.

NPJ Vaccines. 2023-4-6

[3]
Platforms, advances, and technical challenges in virus-like particles-based vaccines.

Front Immunol. 2023

[4]
A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration.

Membranes (Basel). 2022-12-9

[5]
Components of a HIV-1 vaccine mediate virus-like particle (VLP)-formation and display of envelope proteins exposing broadly neutralizing epitopes.

Virology. 2022-3

[6]
Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.

Front Microbiol. 2022-1-3

[7]
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.

Nat Med. 2021-12

[8]
A Four-Step Purification Process for Gag VLPs: From Culture Supernatant to High-Purity Lyophilized Particles.

Vaccines (Basel). 2021-10-9

[9]
Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.

Front Immunol. 2021

[10]
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.

J Nanobiotechnology. 2021-2-25

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索